News Takeda finalises buyout of TiGenix Japanese pharma giant Takeda has completed its buyout of TiGenix.
News Takeda to buy stem cell specialists TiGenix for $626m Decision follows EU regulators' decision to back Crohn's stem cell therapy
News First ever 'off the shelf' stem cell therapy nears European ... Alofisel recommended for complex perianal fistulas in Crohn's disease
News 'Diabetes Barbie' launches with medtech accessories Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
